Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery

AM Abou-Setta, HG Al-Inany, Cindy Farquhar
In: Cochrane Database of Systematic Reviews · 2005 · doi:10.1002/14651858.cd005072 · W4247971716
Other OA: closed CC0 ⤵ 9 in-corpus citations
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This protocol outlines a Cochrane Review to evaluate if a levonorgestrel-releasing intrauterine device after endometriosis surgery reduces pain and recurrence compared to surgery alone, placebo, or systemic treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine if the use of levonorgestrel intrauterine system (LNG‐IUS) post‐operatively in women undergoing surgery for endometriosis compared with those treated with surgery only, placebo (inert IUD) or systemic treatment improves pain symptoms and reduces recurrence.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (37)

Cited by (8)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0 · commercial use OK